Spain: sales value of drugs for peptic ulcer and related diseases 2022

Total sales value of drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) in Spain from 2010 to 2022 (in million euros)

Sales value of drugs for peptic ulcer and related diseases in Spain 2010-2022

Last update:

Aug 7, 2024

Author:

��ƽ�� Research Department

Region:

Spain

Survey time period:

From 01/01/2010 to 31/12/2022

The pharmaceutical sales of drugs for peptic ulcer and gastro-oesophageal reflux diseases (gord) in Spain increased by 21.6 million (+4.28 percent) in 2022. In total, the sales amounted to 526.7 million in 2022.

Find more statistics on other topics about Spain with key insights such as total sales value of lipid modifying agents and total value of cardiac glycosides pharmaceutical sales.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Total sales value of drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) in Spain from 2010 to 2022 (in million euros)

Get in touch with us for additional information

��ƽ��